Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Explore the science of Retatrutide, the first-of-its-kind triple hormone receptor agonist
doi: 10.3390/molecules19079257 74 RobertsD
Older adults, people starting with low muscle mass, and individuals consuming too little protein or performing little resistance exercise may require particular attention to strength and physical function
Exclusivity map: what drives date-to-competition For prescription small molecules, competition timing typically reflects: Patent expiration (composition-of-matter, formulation, method-of-use) Regulatory exclusivity (orphan drug exclusivity where applicable) Any patent settlements that resolve Paragraph IV-type threats Commercial modeling of risk If exclusivity remains intact, follow-on competition is more likely to be better contracting (rebate changes, step edits to prior auth) rather than new chemical entity entry
Kulkarni PS, Padmapriyadarsini C, Vekemans J, Bavdekar A, Gupta M, Kulkarni P, Garg BS, Gogtay NJ, Tambe M, Lalwani S, Singh K, Munshi R, Meshram S, Selvavinayagam TS, Pandey K, Bhimarasetty DM, Ramakrishnan SR, Bhamare C, Dharmadhikari A, Budhawant C, Bonhomme CJ, Thakar M, Kurle SN, Kelly EJ, Gautam M, Gupta N, Panda S, Bhargava B, Poonawalla CS, Shaligram U, Kapse D, Gunale B, Kawade A, Gondhali A, Singh MP, Mohindra R, Pereiera P, Narayana Murthy MR, Raut AV, Maliye C, Kalantri A, Chaudhari VLL, Godbole CJ, Parande M, Salunke N, Palkar S, Hanumante N, Chaudhari P, Karande S, Kumbhar D, Gupta S, Mitra S, Sudharshini S, Venkatesan P, - M, Sen A, Sreegiri S, Vithanala VDP, Panneerselvam T, Nair AM, Chaudhari A, Patil S
These improvements may prove critical for women with PCOS should GLP-1 medications obtain the appropriate authorisation, as managing weight and insulin resistance can significantly improve overall health and fertility
US$ 27.87
US$ 27.96
US$ 22.23
)
US$ 22.09
